Systematic development of electrospun PLA/PCL fibre hybrid mats: Preparation, material characterisation and application in drug delivery

Differing from general melt polymer blending, a sophisticated electrospinning technique to produce continuous polylactic acid (PLA) and poly(ε-caprolactone) (PCL) hybrid fibers was employed to develop favorable fibrous networks of polymer blends for the application of drug delivery. Three typical co...

Full description

Bibliographic Details
Main Authors: Haroosh, Hazim Jasim Mohammed, Dong, Yu
Other Authors: Stoyko Fakirov
Format: Book Chapter
Published: Wiley VCH 2015
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/40682
_version_ 1848755936223559680
author Haroosh, Hazim Jasim Mohammed
Dong, Yu
author2 Stoyko Fakirov
author_facet Stoyko Fakirov
Haroosh, Hazim Jasim Mohammed
Dong, Yu
author_sort Haroosh, Hazim Jasim Mohammed
building Curtin Institutional Repository
collection Online Access
description Differing from general melt polymer blending, a sophisticated electrospinning technique to produce continuous polylactic acid (PLA) and poly(ε-caprolactone) (PCL) hybrid fibers was employed to develop favorable fibrous networks of polymer blends for the application of drug delivery. Three typical cosolvents, consisting of chloroform (CHCl3)/acetone (C3H6O), chloroform (CHCl3)/methanol (MeOH), and dichloromethane (DCM)/N,N-dimethylformamide (DMF), were employed to form high- and low-molecular-weight PCL solutions at 9  and 15 wt%/v with 8 wt%/v PLA, respectively. Such systematic development focused on investigating the effects of polymeric solution variables, such as solution viscosity, polymer molecular weight, solution concentration, polymer blend ratio, and solvent types, on fiber diameters, morphological structures, and thermal properties associated with the degree of crystallinity and rates of drug release. The results show that the formation of bead-free hybrid fibers is ascribed to the increased molecular weight and concentration of polymer solutions. The molecular weight of PCL and cosolvent type have greatly influenced the degree of crystallinity and thermal parameters such as glass transition temperature (Tg), melting temperature (Tm), crystallization temperature (Tc) of PCL components in polymer blends. Finally, the biodegradation rate is accelerated when blending PLA/PCL with a low PCL concentration of 9 wt%/v while the slower release rate of tetracycline hydrochloride drug (TCH) is revealed in the blends with a high PCL concentration of 15 wt%/v.
first_indexed 2025-11-14T09:04:13Z
format Book Chapter
id curtin-20.500.11937-40682
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:04:13Z
publishDate 2015
publisher Wiley VCH
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-406822017-09-13T13:41:44Z Systematic development of electrospun PLA/PCL fibre hybrid mats: Preparation, material characterisation and application in drug delivery Haroosh, Hazim Jasim Mohammed Dong, Yu Stoyko Fakirov fibres material characterisation electrospinning poly(e-caprolactone) (PCL) drug delivery polylactic acid (PLA) Differing from general melt polymer blending, a sophisticated electrospinning technique to produce continuous polylactic acid (PLA) and poly(ε-caprolactone) (PCL) hybrid fibers was employed to develop favorable fibrous networks of polymer blends for the application of drug delivery. Three typical cosolvents, consisting of chloroform (CHCl3)/acetone (C3H6O), chloroform (CHCl3)/methanol (MeOH), and dichloromethane (DCM)/N,N-dimethylformamide (DMF), were employed to form high- and low-molecular-weight PCL solutions at 9  and 15 wt%/v with 8 wt%/v PLA, respectively. Such systematic development focused on investigating the effects of polymeric solution variables, such as solution viscosity, polymer molecular weight, solution concentration, polymer blend ratio, and solvent types, on fiber diameters, morphological structures, and thermal properties associated with the degree of crystallinity and rates of drug release. The results show that the formation of bead-free hybrid fibers is ascribed to the increased molecular weight and concentration of polymer solutions. The molecular weight of PCL and cosolvent type have greatly influenced the degree of crystallinity and thermal parameters such as glass transition temperature (Tg), melting temperature (Tm), crystallization temperature (Tc) of PCL components in polymer blends. Finally, the biodegradation rate is accelerated when blending PLA/PCL with a low PCL concentration of 9 wt%/v while the slower release rate of tetracycline hydrochloride drug (TCH) is revealed in the blends with a high PCL concentration of 15 wt%/v. 2015 Book Chapter http://hdl.handle.net/20.500.11937/40682 10.1002/9783527656950.ch8 Wiley VCH restricted
spellingShingle fibres
material characterisation
electrospinning
poly(e-caprolactone) (PCL)
drug delivery
polylactic acid (PLA)
Haroosh, Hazim Jasim Mohammed
Dong, Yu
Systematic development of electrospun PLA/PCL fibre hybrid mats: Preparation, material characterisation and application in drug delivery
title Systematic development of electrospun PLA/PCL fibre hybrid mats: Preparation, material characterisation and application in drug delivery
title_full Systematic development of electrospun PLA/PCL fibre hybrid mats: Preparation, material characterisation and application in drug delivery
title_fullStr Systematic development of electrospun PLA/PCL fibre hybrid mats: Preparation, material characterisation and application in drug delivery
title_full_unstemmed Systematic development of electrospun PLA/PCL fibre hybrid mats: Preparation, material characterisation and application in drug delivery
title_short Systematic development of electrospun PLA/PCL fibre hybrid mats: Preparation, material characterisation and application in drug delivery
title_sort systematic development of electrospun pla/pcl fibre hybrid mats: preparation, material characterisation and application in drug delivery
topic fibres
material characterisation
electrospinning
poly(e-caprolactone) (PCL)
drug delivery
polylactic acid (PLA)
url http://hdl.handle.net/20.500.11937/40682